Literature DB >> 25320242

Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.

Fabian Stavenuiter1, Laurent O Mosnier1.   

Abstract

Endothelial barrier protective effects of activated protein C (APC) require the endothelial protein C receptor (EPCR), protease-activated receptor (PAR) 1, and PAR3. In contrast, PAR1 and PAR3 activation by thrombin results in barrier disruption. Noncanonical PAR1 and PAR3 activation by APC vs canonical activation by thrombin provides an explanation for the functional selectivity of these proteases. Here we found that factor Xa (FXa) activated PAR1 at canonical Arg41 similar to thrombin but cleaved PAR3 at noncanonical Arg41 similar to APC. This unique PAR1-PAR3 activation profile permitted the identification of noncanonical PAR3 activation as a novel activation pathway for barrier protective tunica intima endothelial receptor tyrosine kinase 2 (Tie2). APC, FXa, and the noncanonical PAR3 tethered-ligand peptide induced prolonged activation of Tie2, whereas thrombin and the canonical PAR3 tethered-ligand peptide did not. Tie2 activation by FXa required PAR3 and EPCR. FXa and the noncanonical PAR3 tethered-ligand peptide induced Tie2- and PAR3-dependent upregulation of tight-junction-associated protein zona occludens 1 (ZO-1), translocation of ZO-1 to cell-cell borders, and the formation of typical ZO-1 honeycomb patterns that are indicative of tight-junction stabilization. These data provide intriguing novel insights into the diversification of functional selectivity of protease signaling achievable by canonical and noncanonical PAR activation, such as the activation of vascular-protective Tie2 by noncanonical PAR3 activation.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320242      PMCID: PMC4246042          DOI: 10.1182/blood-2014-06-582775

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.

Authors:  A Cumashi; H Ansuini; N Celli; A De Blasi; P J O'Brien; L F Brass; M Molino
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

2.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.

Authors:  Joseph N McLaughlin; Myla M Patterson; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

3.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

4.  Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1.

Authors:  Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

5.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

6.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

Review 7.  Dual regulation of endothelial junctional permeability.

Authors:  Yulia A Komarova; Dolly Mehta; Asrar B Malik
Journal:  Sci STKE       Date:  2007-11-13

8.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.

Authors:  Nicole C Kaneider; Andrew J Leger; Anika Agarwal; Nga Nguyen; George Perides; Claudia Derian; Lidija Covic; Athan Kuliopulos
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

9.  Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

Authors:  Laurent O Mosnier; Antonella Zampolli; Edward J Kerschen; Reto A Schuepbach; Yajnavalka Banerjee; José A Fernández; Xia V Yang; Matthias Riewald; Hartmut Weiler; Zaverio M Ruggeri; John H Griffin
Journal:  Blood       Date:  2009-02-24       Impact factor: 22.113

10.  Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.

Authors:  Huang Guo; Dong Liu; Harris Gelbard; Tong Cheng; Rae Insalaco; José A Fernández; John H Griffin; Berislav V Zlokovic
Journal:  Neuron       Date:  2004-02-19       Impact factor: 17.173

View more
  18 in total

1.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

2.  Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo.

Authors:  Laura D Healy; Cristina Puy; José A Fernández; Annachiara Mitrugno; Ravi S Keshari; Nyiawung A Taku; Tiffany T Chu; Xiao Xu; András Gruber; Florea Lupu; John H Griffin; Owen J T McCarty
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

Review 3.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 4.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 5.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

6.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

7.  Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.

Authors:  Nikita Minhas; Meilang Xue; Christopher J Jackson
Journal:  Cell Mol Life Sci       Date:  2016-12-22       Impact factor: 9.261

Review 8.  Relationship between G proteins coupled receptors and tight junctions.

Authors:  Lorenza González-Mariscal; Arturo Raya-Sandino; Laura González-González; Christian Hernández-Guzmán
Journal:  Tissue Barriers       Date:  2018-02-08

Review 9.  Dynamic interactions of Plasmodium spp. with vascular endothelium.

Authors:  Mark R Gillrie; May Ho
Journal:  Tissue Barriers       Date:  2016-12-07

Review 10.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.